This is in agreement with the growth-inhibitory effect of NR4A2 silencing detected in breast cancer [26], colon cancer [16] and intestinal epithelial cells [27] and suggests a different role for NR4A2 in HSCs and HPCs proliferation. Here, NR4A2 is linked to breast cancer.